ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 77 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,768,968 | -11.4% | 3,549,959 | +5.1% | 0.00% | 0.0% |
| Q2 2023 | $3,125,352 | +151.6% | 3,378,758 | +196.5% | 0.00% | – |
| Q1 2023 | $1,242,075 | +231.9% | 1,139,518 | +344.5% | 0.00% | – |
| Q4 2022 | $374,252 | -77.7% | 256,337 | -83.6% | 0.00% | – |
| Q3 2022 | $1,677,000 | -37.0% | 1,559,786 | -0.3% | 0.00% | -100.0% |
| Q2 2022 | $2,660,000 | -27.9% | 1,564,755 | -12.6% | 0.00% | 0.0% |
| Q1 2022 | $3,688,000 | -37.8% | 1,790,391 | +13.2% | 0.00% | 0.0% |
| Q4 2021 | $5,933,000 | -58.4% | 1,582,079 | -42.7% | 0.00% | -66.7% |
| Q3 2021 | $14,278,000 | +1224.5% | 2,761,728 | +991.2% | 0.00% | – |
| Q2 2021 | $1,078,000 | -92.1% | 253,102 | -90.1% | 0.00% | -100.0% |
| Q1 2021 | $13,563,000 | +29.5% | 2,554,252 | +31.5% | 0.00% | 0.0% |
| Q4 2020 | $10,471,000 | -73.7% | 1,942,664 | -61.1% | 0.00% | -72.7% |
| Q3 2020 | $39,816,000 | +16.4% | 4,989,446 | +46.0% | 0.01% | -8.3% |
| Q2 2020 | $34,197,000 | +498.2% | 3,416,268 | +62.5% | 0.01% | +300.0% |
| Q1 2020 | $5,717,000 | +19613.8% | 2,101,805 | +10984.3% | 0.00% | – |
| Q3 2019 | $29,000 | -90.9% | 18,962 | -75.9% | 0.00% | – |
| Q2 2019 | $317,000 | +1.6% | 78,755 | +8.4% | 0.00% | – |
| Q1 2019 | $312,000 | +16.4% | 72,666 | +55.6% | 0.00% | – |
| Q4 2018 | $268,000 | -92.8% | 46,688 | -82.9% | 0.00% | -100.0% |
| Q3 2018 | $3,697,000 | +142.7% | 272,689 | +112.6% | 0.00% | 0.0% |
| Q2 2018 | $1,523,000 | +1169.2% | 128,280 | +1098.9% | 0.00% | – |
| Q1 2018 | $120,000 | -82.4% | 10,700 | -87.2% | 0.00% | -100.0% |
| Q3 2017 | $683,000 | +667.4% | 83,423 | +322.2% | 0.00% | – |
| Q2 2017 | $89,000 | -98.9% | 19,759 | -97.0% | 0.00% | -100.0% |
| Q3 2015 | $7,844,000 | +142.2% | 655,279 | +270.7% | 0.01% | +133.3% |
| Q2 2015 | $3,239,000 | – | 176,760 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 6,287,101 | $4,903,939 | 2.63% |
| Syncona Portfolio Ltd | 1,377,294 | $1,074,289 | 1.60% |
| MPM BioImpact LLC | 5,095,912 | $3,974,811 | 1.06% |
| NEA Management Company, LLC | 17,079,778 | $13,322,227 | 1.03% |
| TANG CAPITAL MANAGEMENT LLC | 5,166,954 | $4,030,224 | 0.57% |
| PFM Health Sciences, LP | 10,423,135 | $8,130,045 | 0.38% |
| Matrix Capital Management Company, LP | 38,974,185 | $30,399,864 | 0.36% |
| Long Focus Capital Management, LLC | 10,963,158 | $8,551,263 | 0.31% |
| Acuitas Investments, LLC | 479,764 | $374,216 | 0.22% |
| Endurant Capital Management LP | 311,944 | $243,316 | 0.22% |